Karen Ferrante
Director/Board Member at MACROGENICS, INC.
Net worth: 46 354 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Scott Koenig | M | 71 | 24 years | |
| Jessica Sachs | M | 49 | 12 years | |
| David Mims | M | 60 | 5 years | |
| Peter Harwin | M | 38 | 4 years | |
| Andrew Robbins | M | 48 | 4 years | |
| Douglas Lankler | M | 58 | 25 years | |
| Margaret Liu | M | 66 | 1 years | |
| Matthew Ros | M | 57 | 5 years | |
| Chris Cain | M | 40 | 4 years | |
| Evan Kearns | M | 43 | 3 years | |
| Jay Siegel | M | 71 | 7 years | |
| Jeffrey Peters | M | 53 | 9 years | |
| Eric Risser | M | 51 | 15 years | |
| Meenu Chhabra Karson | F | 51 | 1 years | |
| James Karrels | M | 57 | 16 years | |
| Todd Shegog | M | 59 | 3 years | |
| Paul Carter | M | 63 | 7 years | |
| Scott Jackson | M | 59 | 7 years | |
| David Stump | M | 74 | 11 years | |
| Edward Hurwitz | M | 60 | 20 years | |
| Graeme Jack | M | 73 | 7 years | |
| John Green | M | 43 | 6 years | |
| Arlene Morris | F | 72 | 5 years | |
| William Heiden | M | 64 | 2 years | |
| Lynn Cilinski | F | 66 | 21 years | |
| Federica O’Brien | F | 66 | 3 years | |
| Ezio Bonvini | M | 70 | 21 years | |
| Dana Martin | M | - | 3 years | |
| Michael Shi | M | 59 | 2 years | |
| Annaliesa Anderson | M | - | 17 years | |
| Christopher O'Reilly | M | - | 13 years | |
| Markus Green | M | - | 18 years | |
| Mike McDermott | M | 58 | 21 years | |
| Brad Barnett | M | - | - | |
| Erin Schellhammer | F | - | - | |
| Sara Saltzman | F | - | 5 years | |
| Mwana Lugogo | M | 54 | 12 years | |
| Thomas Spitznagel | M | 57 | 11 years | |
| John Robinson | M | 50 | 3 years | |
| Christi Waarich | F | - | - | |
| Syd Johnson | M | - | 23 years | |
| Stephen Eck | M | 69 | 4 years | |
| Suneet Varma | M | 55 | 23 years | |
| Rachael Easton | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Kindler | M | 68 | 8 years | |
| Mark Robert Baker | M | 69 | 14 years | |
| Chuck Wilson | M | 59 | 6 years | |
| Henry McKinnell | M | 81 | 8 years | |
| Patrick Fabbio | M | 56 | 5 years | |
| Dennis Ausiello | M | 78 | 13 years | |
| Christian Hogg | M | 58 | 16 years | |
| Paulo Costa | M | 73 | 13 years | |
| Nicole S. Williams | F | 79 | 12 years | |
| Ludwig Hantson | M | 61 | 1 years | |
| Iwaaki Taniguchi | M | - | - | |
| George A. Lorch | M | 82 | 15 years | |
| Bruce Booth | M | 49 | 6 years | |
| Angelo William Lovallo | M | 59 | 7 years | |
| Shiro Kuniya | M | 67 | - | |
| Christiana Stamoulis | F | 53 | 4 years | |
| Peter J. Crowley | M | 65 | 10 years | |
| Fumio Sudo | M | 83 | 6 years | |
| Antonio Gualberto | M | 59 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 13 years |
| Jonathan Emms | M | - | 20 years | |
| Stephen Buckley | M | 74 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | - |
| Frank Morich | M | 69 | 4 years | |
| Paul Fitzhenry | M | 63 | 4 years | |
| Christopher Huang | M | 72 | 11 years | |
| Christopher S. James | M | - | 1 years | |
| Liam Ratcliffe | M | 60 | 4 years | |
| Campbell Murray | M | 48 |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 5 years |
| Daniel Curran | M | 57 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 13 years |
| Jacob M. Plotsker | M | 56 | 16 years | |
| Reinhard Ambros | M | 67 |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 5 years |
| Robert Perez | M | 59 | 1 years | |
| Matthew Fust | M | 59 | 6 years | |
| Susan Stewart | F | 64 |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 6 years |
| Peter Corr | M | 76 | 6 years | |
| Blake E. Devitt | M | 77 | 1 years | |
| Deborah Dunsire | M | 61 | 3 years | |
| Michael R. Jirousek | M | 65 | 5 years | |
| Bradley Campbell | M | 48 | 4 years | |
| Cheryl Cohen | F | 58 |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | 5 years |
| Robert N. Burt | M | 86 | 11 years | |
| Gail Fosler | F | 76 | 1 years | |
| Albert P. L. Stroucken | M | 76 | 1 years | |
| William Herbert Gray | M | 82 | 13 years | |
| George Milne | M | 80 | 32 years | |
| Olivier Brandicourt | M | 68 | 13 years | |
| Tadataka Yamada | M | 77 | 4 years | |
| David Scheinberg | M | 68 | 25 years | |
| Ken Galbraith | M | 61 | 14 years | |
| Yorihiko Kojima | M | 82 | - | |
| Michael William Davis Howell | M | 76 | 11 years | |
| Hiroshi Shinha | M | - | 38 years | |
| Matthew Osborne | M | - | 1 years | |
| Marsha Fanucci | F | 70 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 9 years |
| Nancy Simonian | M | 63 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 10 years |
| Jeffrey D. Summer | M | 64 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 83 | 83.84% |
| Japan | 12 | 12.12% |
| Hong Kong | 6 | 6.06% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Karen Ferrante
- Personal Network
